Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer Inc.    PFE

PFIZER INC.

(PFE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/26/2020 10/27/2020 10/28/2020 10/29/2020 10/30/2020 Date
37.92(c) 37.43(c) 35.45(c) 35.28(c) 35.48(c) Last
32 052 303 34 963 528 32 122 867 26 134 103 24 140 812 Volume
-0.68% -1.29% -5.29% -0.48% +0.57% Change
More quotes
Financials (USD)
Sales 2020 48 968 M - -
Net income 2020 13 308 M - -
Net Debt 2020 40 882 M - -
P/E ratio 2020 17,1x
Yield 2020 4,28%
Sales 2021 51 301 M - -
Net income 2021 12 506 M - -
Net Debt 2021 26 866 M - -
P/E ratio 2021 15,6x
Yield 2021 4,45%
Capitalization 196 B 196 B -
EV / Sales 2020 4,84x
EV / Sales 2021 4,35x
Nbr of Employees 88 300
Free-Float 59,1%
More Financials
Company
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines... 
Sector
Pharmaceuticals
Calendar
11/05Ex-dividend day for
More about the company
Notations Surperformance© of Pfizer Inc.
Trading Rating : Investor Rating :
More Ratings
All news about PFIZER INC.
05:12pPFIZER INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02:09pPfizer, Mylan Agreement With FTC Over Upjohn Deal, Clearing Way for November ..
DJ
01:40pPFIZER : Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commissi..
PR
01:23pPFIZER : Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commissi..
BU
01:16pJ&J plans to test its COVID-19 vaccine in ages 12-18 soon
RE
07:11aPfizer, Astra Vaccine With Oxford Under Accelerated UK Reviews- Bloomberg Ne..
RE
02:39aBioNTech CEO expects data from late-stage study soon
RE
10/29BIONTECH : Germany Aims to Start Coronavirus Vaccination This Year -- Update
DJ
10/29EU to fund transfer of COVID-19 patients across borders to prevent hospitals ..
RE
10/29EU Commission says talking to four companies on COVID vaccine
RE
10/29Fauci says first U.S. COVID-19 vaccines could ship late December or early Jan..
RE
10/29BIONTECH : Germany Aims to Start Coronavirus Vaccination This Year
DJ
10/29Moderna on track to report late-stage COVID-19 vaccine data next month
RE
10/29Next crop of COVID-19 vaccine developers take more traditional route
RE
10/29Britain expects verdict on Pfizer's COVID-19 vaccine before AstraZeneca's - T..
RE
More news
News in other languages on PFIZER INC.
10/29Börse Stuttgart-News: Euwax Trends
10/29Moderna bereitet Start von Corona-Impfstoff vor
10/29Moderna a déjà reçu 1,1 milliard de dollars de dépôts pour son vaccin anti-Co..
10/28US-EXPERTE FAUCI : Vor Januar wird es keinen Corona-Impfstoff geben
10/27Wall Street hésite entre craintes politiques et prouesses technologiques
More news
Analyst Recommendations on PFIZER INC.
More recommendations
Stock Trading Strategies
PFIZER INC. - 10/20
Close to new upside potential
BUY
More Stock Trading Analysis
Chart PFIZER INC.
Duration : Period :
Pfizer Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 42,21 $
Last Close Price 35,48 $
Spread / Highest target 55,0%
Spread / Average Target 19,0%
Spread / Lowest Target -1,35%
EPS Revisions
Managers
NameTitle
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Wyllie Don Cornwell Independent Director
Suzanne Nora Johnson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC.-9.44%196 047
JOHNSON & JOHNSON-5.95%361 159
ROCHE HOLDING AG-6.40%274 461
MERCK & CO., INC.-16.56%191 944
NOVARTIS AG-22.62%176 518
NOVO NORDISK A/S9.93%154 639